Search

everythinglearnresearchcommunity

for

Search:↓

Estrogen Receptor ß (ERß) is the main hormone controller in human skin and hair follicles, not Estrogen Receptor α (ERα) or the Androgen Receptor (AR).

Hair from people with seborrheic dermatitis is thicker scaled, more damaged, and thinner than healthy hair, and atomic force microscopy can help monitor the condition.

The study found specific hair and scalp patterns for different types of hair loss in Koreans, noting racial differences affect diagnosis.

Patients with certain baseline characteristics are more likely to benefit early from baricitinib for alopecia areata.

Patients with skin diseases rated psychological effects as most impactful, needing a treatment approach that addresses both mind and body.

COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.

Test thyroid function in all obese patients and prioritize weight loss for hormonal balance.

Non-immune factors play a significant role in alopecia areata.

Both topical calcipotriol and narrowband UVB improved alopecia, but combining them didn't enhance the effect on hair loss severity, despite higher vitamin D3 levels.

Previous alopecia areata treatments do not affect the long-term effectiveness of ritlecitinib.

Routine monitoring isn't needed for healthy patients on low-dose oral minoxidil, but is advised for those with kidney issues.

COVID-19 can cause different types of hair loss, with telogen effluvium being the most common.

Chronic tonsillitis is linked to NETosis activity, which may help tailor treatments and reduce tonsil removal surgeries.

Rhabdomyosarcoma is the most common head and neck cancer in children, requiring complex treatment.

Human hair follicle stem cells show signs of low oxygen levels, which may be important for hair growth and preventing baldness.

The Nd:YAG laser safely reduces facial hair and slows regrowth, with patient satisfaction.

AGA progression involves increased lipid synthesis, electron transport, and hair follicle miniaturization.

Skin problems are common in lupus patients and should be treated early to prevent worsening.

5% topical minoxidil improves hair density and quality in monilethrix patients.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

Chronic granulomatous disease may be linked to developing systemic lupus erythematosus.

Anti-CD19 therapy may help treat SLE and NMOSD.

Exosome treatment safely increases hair density in male patients with androgenetic alopecia.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Low-level laser therapy effectively reduces the size of pressure ulcers compared to placebo.

The study concluded that scalp tumors show different patterns based on age, gender, and tumor thickness, and emphasized the importance of early detection and scalp examinations.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Magnetic fields help create complex 3D soft structures for biomedical use.

Hair analysis can track past cortisol levels in Cushing's Syndrome patients.

RANK is a key target in breast cancer treatment due to its role in tumor growth and bone metastasis.